Use of Clopidogrel, Prasugrel, or Ticagrelor and Patient Outcome after Acute Coronary Syndrome in Austria from 2015 to 2017

Use of Clopidogrel, Prasugrel, or Ticagrelor and Patient Outcome after Acute Coronary Syndrome in Austria from 2015 to 2017

Background: Dual antiplatelet therapy improves patient outcome after acute coronary syndrome (ACS), but prescription differences of P2Y12 inhibitor treatments exist. The aim of the present investigation was to study the long-term utilization and patient outcomes of clopidogrel, prasugrel, and ticagr...

Full description

Bibliographic Details
Main Authors: Safoura Sheikh Rezaei, Andreas Gleiss, Berthold Reichardt, Michael Wolzt
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Journal of Clinical Medicine
Subjects:
ACS
DAPT
P2Y12 inhibitors
pharmacoepidemiology
Online Access:https://www.mdpi.com/2077-0383/9/11/3398

Similar Items

Similar Items